Palatin Technologies (PTN) will transfer its common stock listing to Nasdaq Capital Market from NYSE American later this month, the biopharmaceutical company said late Monday.
The company's common stock will continue trading on the NYSE American until May 28 and is expected to begin Nasdaq trading May 29 under the existing ticker, it said.
The Nasdaq listing should "improve the visibility" of the stock, improve trading liquidity and increase exposure to institutional investors, Chief Executive Carl Spana said.